RPG Life Sciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Jun' 24	Mar' 24	Dec' 23	Sep' 23	Jun' 23

Sales

165.42

126.99

153.70

153.58

147.78

Operating profit

39.07

20.72

37.90

37.29

32.24

Interest

0.15

0.14

0.14

0.10

0.07

Gross profit

41.29

22.23

39.68

39.02

33.98

EPS (Rs)

16.18

8.01

16.00

15.64

13.36

Other income

2.37

1.65

1.92

1.83

1.81

Stock adjustment

-2.25

-1.51

6.83

-5.67

3.05

Raw material

32.37

28.03

24.85

37.30

30.47

Power and fuel

-

-

-

-

-

Employee expenses

32.74

32.08

33.69

33.59

32.79

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

63.49

47.67

50.43

51.07

49.23

Provisions made

-

-

-

-

-

Depreciation

5.29

4.49

4.14

4.23

4.21

Taxation

9.24

4.50

9.08

8.93

7.67

Net profit / loss

26.76

13.24

26.46

25.86

22.10

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

13.23

13.23

13.23

13.23

13.23

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

23.62

16.32

24.66

24.28

21.82

GPM (%)

24.61

17.28

25.50

25.11

22.72

NPM (%)

15.95

10.29

17.00

16.64

14.77